FGEN logo

FibroGen (FGEN) Accounts Payable

Annual Accounts Payable

$17.96 M
-$12.80 M-41.61%

31 December 2023

FGEN Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$9.24 M
-$700.00 K-7.04%

30 September 2024

FGEN Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FGEN Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-41.6%-51.9%
3 y3 years-27.6%-61.3%
5 y5 years+96.5%+127.8%

FGEN Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-41.6%at low-87.0%+112.2%
5 y5 years-41.6%+195.0%-87.0%+222.4%
alltimeall time-41.6%+1584.8%-87.0%+766.6%

FibroGen Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$9.24 M(-7.0%)
June 2024
-
$9.94 M(+128.3%)
Mar 2024
-
$4.35 M(-75.8%)
Dec 2023
$17.96 M(-41.6%)
$17.96 M(-6.6%)
Sept 2023
-
$19.22 M(+50.1%)
June 2023
-
$12.80 M(-82.0%)
Mar 2023
-
$71.28 M(+131.8%)
Dec 2022
$30.76 M(+17.9%)
$30.76 M(+59.2%)
Sept 2022
-
$19.32 M(-34.2%)
June 2022
-
$29.36 M(-19.2%)
Mar 2022
-
$36.35 M(+39.3%)
Dec 2021
$26.10 M(+5.3%)
$26.10 M(+9.3%)
Sept 2021
-
$23.87 M(-51.3%)
June 2021
-
$48.99 M(+103.6%)
Mar 2021
-
$24.06 M(-2.9%)
Dec 2020
$24.79 M(+307.2%)
$24.79 M(+228.2%)
Sept 2020
-
$7.55 M(+50.6%)
June 2020
-
$5.01 M(+75.0%)
Mar 2020
-
$2.87 M(-52.9%)
Dec 2019
$6.09 M
$6.09 M(+50.1%)
Sept 2019
-
$4.05 M(-0.1%)
June 2019
-
$4.06 M(+7.6%)
DateAnnualQuarterly
Mar 2019
-
$3.77 M(-58.7%)
Dec 2018
$9.14 M(+65.9%)
$9.14 M(-9.8%)
Sept 2018
-
$10.13 M(+214.4%)
June 2018
-
$3.22 M(-9.2%)
Mar 2018
-
$3.55 M(-35.6%)
Dec 2017
$5.51 M(-11.5%)
$5.51 M(-14.0%)
Sept 2017
-
$6.41 M(+96.5%)
June 2017
-
$3.26 M(+10.5%)
Mar 2017
-
$2.95 M(-52.6%)
Dec 2016
$6.22 M(-4.6%)
$6.22 M(+205.2%)
Sept 2016
-
$2.04 M(-41.3%)
June 2016
-
$3.47 M(+125.1%)
Mar 2016
-
$1.54 M(-76.3%)
Dec 2015
$6.52 M(+43.3%)
$6.52 M(+54.0%)
Sept 2015
-
$4.23 M(+8.1%)
June 2015
-
$3.92 M(+60.9%)
Mar 2015
-
$2.43 M(-46.5%)
Dec 2014
$4.55 M(+326.9%)
$4.55 M(+57.2%)
Sept 2014
-
$2.90 M(+130.5%)
June 2014
-
$1.26 M(+17.8%)
Dec 2013
$1.07 M(-65.7%)
$1.07 M
Dec 2012
$3.11 M
-

FAQ

  • What is FibroGen annual accounts payable?
  • What is the all time high annual accounts payable for FibroGen?
  • What is FibroGen annual accounts payable year-on-year change?
  • What is FibroGen quarterly accounts payable?
  • What is the all time high quarterly accounts payable for FibroGen?
  • What is FibroGen quarterly accounts payable year-on-year change?

What is FibroGen annual accounts payable?

The current annual accounts payable of FGEN is $17.96 M

What is the all time high annual accounts payable for FibroGen?

FibroGen all-time high annual accounts payable is $30.76 M

What is FibroGen annual accounts payable year-on-year change?

Over the past year, FGEN annual accounts payable has changed by -$12.80 M (-41.61%)

What is FibroGen quarterly accounts payable?

The current quarterly accounts payable of FGEN is $9.24 M

What is the all time high quarterly accounts payable for FibroGen?

FibroGen all-time high quarterly accounts payable is $71.28 M

What is FibroGen quarterly accounts payable year-on-year change?

Over the past year, FGEN quarterly accounts payable has changed by -$9.98 M (-51.94%)